Dexmedetomidine Hydrochlorid · 2,345 days since initial FDA posting
Brand: DEXMEDETOMIDINE
FDA lists Dexmedetomidine Hydrochlorid as Active Shortage (HQ Specialty Pharma).
Availability on file: Available
Dexmedetomidine Hydrochloride Injection: Active Shortage
Available Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Dexmedetomidine Hydrochloride Injection
- Manufacturer
- HQ Specialty Pharma
- Dosage Form
- Injection
- Presentation
- Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 44567-600-04)
- Package NDC
- 44567-600-04
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Apr 10, 2020
- Last Updated
- Mar 18, 2026
- Therapeutic Category
- Anesthesia
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Marketed by WG Critical Care
Nearby, Other Dexmedetomidine Shortage Records
Dexmedetomidine Hydrochloride Injection
Gland Pharma Limited
Injection
Dexmedetomidine Hydrochloride Injection
Gland Pharma Limited
Injection
Dexmedetomidine Hydrochloride Injection
Gland Pharma Limited
Injection
Dexmedetomidine Hydrochloride Injection
Slayback Pharma
Injection
Dexmedetomidine Hydrochloride Injection
Slayback Pharma
Injection
Dexmedetomidine Hydrochloride Injection
Meitheal Pharmaceuticals, Inc.
Injection
FDA reason on file: Marketed by WG Critical Care. General shortage guidance lives on the tracker hub.